Clinical Trials Logo

Filter by:
  • Withdrawn  
  • « Prev · Page [3]
NCT ID: NCT01756820 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial

CTS-HV
Start date: January 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether Single-portal Endoscopic Carpal Tunnel Release (Agee technique, SmartReleaseā„¢, MicroAire) and mini-open technique (Knifelight®, Stryker) are equally effective and safe surgical options for the treatment of primary Carpal Tunnel Syndrome.

NCT ID: NCT00987662 Withdrawn - Obesity Clinical Trials

Irbesartan Versus Amlodipine: The OBI Study

OBI
Start date: January 2012
Phase: Phase 4
Study type: Interventional

Objective: 1. To study the effectiveness of irbesartan 300mg and amlodipine 10 mg in 24h ambulatory blood pressure values in obese subjects 2. To study the drug specific effect in arterial stiffness 3. To study possible drug mechanisms in obesity (reduction of central adiposity and changing the ratio of leptin to adiponectin)

NCT ID: NCT00755157 Withdrawn - Clinical trials for Small Cell Lung Cancer

Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer

Start date: April 2008
Phase: Phase 2
Study type: Interventional

This trial will evaluate the efficacy and safety of metronomic docetaxel and bevacizumab combination in patients with pretreated, advanced small cell lung cancer.

NCT ID: NCT00559143 Withdrawn - Clinical trials for Atrioventricular Block

Biventricular Alternative Pacing

BETTER
Start date: November 2007
Phase: Phase 4
Study type: Interventional

Aim of present study is to examine the short and long-term results of pacing from right ventricular apex and to compare them with those of biventricular pacing.

NCT ID: NCT00478270 Withdrawn - Pain Clinical Trials

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Start date: June 2007
Phase: Phase 2
Study type: Interventional

This single arm study will assess the efficacy of loading doses of intravenous Bondronat in reducing pain in patients with breast cancer and metastatic bone disease experiencing moderate to severe bone pain. Patients will receive an intravenous infusion of 6mg Bondronat on days 1, 2 and 3. The anticipated time on study treatment is <3 months, and the target sample size is <100 individuals.